New study tests smarter way to open blocked leg arteries

NCT ID NCT06879561

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study compares two methods for opening blocked arteries in the lower leg in people with chronic limb-threatening ischemia, a severe condition that can lead to amputation. One group gets standard balloon angioplasty guided by X-ray images (angiography). The other group uses a special pressure wire to ensure the artery is fully opened. The goal is to see which method better restores blood flow and helps wounds heal. About 100 adults will take part, and they will be followed for 6 months.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Pressure wire-guided balloon angioplasty
What this could lead to
If successful, this could show that using a pressure wire during leg artery treatment leads to better blood flow and faster wound healing for people with severe leg artery disease.
What could go wrong
This is a small, early-stage trial with only 100 participants, so results may not apply to everyone. The pressure wire adds complexity and may not improve outcomes over standard angiography.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC LIMB-THREATENING ISCHEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Chronic Limb-Threatening Ischemia limb ischemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Division of Cardiology, Severance Cardiovascular hospital Department of Internal Medicine, Yonsei University College of Medicine

    RECRUITING

    Seoul, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.